P. Viciana

发表

[Acute brucellosis and HIV infection: a new particularity].

M. D. del Nozal, M. Valladares, P. Viciana, 1993, Enfermedades infecciosas y microbiologia clinica.

Recomendations from GESIDA/National AIDS plan on antiretroviral therapy in adult patients infected by the human immunodeficiency virus (October 2004)

B. Clotet, E. Martinez, S. Moreno, 2015 .

Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load

M. Juan, R. Paredes, B. Clotet, 2004, AIDS.

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy

Á. Camacho, A. Rivero, P. Viciana, 2007, Therapeutic drug monitoring.

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.

F. Vidal, E. Ribera, J. Cosín, 2010, Enfermedades infecciosas y microbiologia clinica.

Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain

B. Clotet, J. Pineda, S. Moreno, 2015, Journal of viral hepatitis.

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.

C. Tural, J. Miro, S. Moreno, 2009, Current HIV research.

Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses

B. Clotet, J. Martinez-Picado, J. Prado, 2018, Journal of Virology.

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.

F. Vidal, E. Ribera, J. Cosín, 2008, The Journal of antimicrobial chemotherapy.

Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus

J. Torre-Cisneros, A. Vergara, P. Viciana, 1996, European Journal of Clinical Microbiology and Infectious Diseases.

Etiology, Clinical Features and Outcome of Splenic Microabscesses in HIV-Infected Patients with Prolonged Fever

M. Bernabeu-Wittel, J. Pachón, J. L. Villanueva, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virus

J. Pachón, P. Viciana, M. Jiménez-Mejías, 1996, Antimicrobial agents and chemotherapy.

Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients

M. González-Escribano, J. Pineda, A. Rivero, 2012, PloS one.

Role of Pegylated Interferon‐α‐2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV‐Coinfected Patients

P. Viciana, L. López-Cortés, A. Terrón, 2008, Clinical pharmacology and therapeutics.

High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance

P. Viciana, L. López-Cortés, N. Espinosa, 2019, Papillomavirus research.

Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors

S. de Sanjosé, R. Geskus, J. del Romero, 2015, AIDS.

Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study

Felipe García, J. Benito, A. León, 2020, Journal of the International AIDS Society.

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients

Felipe García, J. Vicario, F. Díez-Fuertes, 2019, PloS one.

Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers

R. Koup, J. Casazza, E. Ruiz-Mateos, 2012, Journal of Virology.

Anal squamous intraepithelial lesions are frequent among young HIV‐infected men who have sex with men followed up at the Spanish AIDS Research Network Cohort (CoRIS‐HPV)

B. Hernández-Novoa, A. Benito, C. Rodríguez, 2013, International journal of cancer.

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

J. Macías, J. Pineda, Á. Camacho, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohort

J. Cosín, M. Fuentes-Ferrer, P. Viciana, 2011, BMC women's health.

Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial

P. Viciana, L. López-Cortés, N. Espinosa, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients.

D. Podzamczer, B. Clotet, V. Moreno, 2014, The Journal of antimicrobial chemotherapy.

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population

P. Viciana, L. López-Cortés, F. Lozano, 2014, PloS one.

Role of ritonavir in the drug interactions between telaprevir and ritonavir-boosted atazanavir.

P. Viciana, L. López-Cortés, N. Espinosa, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis C virus and human immunodeficiency virus coinfection in Spain.

E. Ribera, J. Cosín, P. Viciana, 2003, The Journal of infection.

Virological and immunological stability in HIV infected patients undergoing partial-treatment interruption.

P. Viciana, L. López-Cortés, Fernando Flor-Parra, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[Recommendations of the Study Group for Metabolic Alterations/Secretariat for the National AIDS Plan (GEAM/SPNS) on the management of metabolic and morphologic alterations in patients with HIV infection].

E. Martinez, S. Johnston, F. Pulido, 2006, Enfermedades infecciosas y microbiologia clinica.

Hyperglycemia associated with protease inhibitors in HIV-1-infected patients.

A. de Alarcón, P. Viciana, M. Jiménez-Mejías, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus

E. Ruiz-Mateos, L. Tarancón-Díez, P. Viciana, 2020, Antimicrobial Agents and Chemotherapy.

Long-term Persistent Elite HIV-controllers: The Right Model of Functional Cure

E. Ruiz-Mateos, L. Tarancón-Díez, B. Domínguez-Molina, 2018, EBioMedicine.

HLA-B*57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers

B. Walker, C. Tural, Xu G. Yu, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

IL28B single-nucleotide polymorphism rs12979860 is associated with spontaneous HIV control in white subjects.

E. Ruiz-Mateos, M. Leal, M. Genebat, 2013, The Journal of infectious diseases.

Plasmacytoid Dendritic Cells Reduce HIV Production in Elite Controllers

E. Ruiz-Mateos, M. Leal, J. Herbeuval, 2012, Journal of Virology.

HIV control in Caucasian subjects

E. Ruiz-Mateos, M. Genebat, M. González-Escribano, 2012 .

Educational Gradient in HIV Diagnosis Delay, Mortality, Antiretroviral Treatment Initiation and Response in a Country with Universal Health Care

J. Blanco, S. Moreno, P. Viciana, 2012, Antiviral therapy.

E. Cordero, M. D. del Nozal, P. Viciana, 1997, Antimicrobial agents and chemotherapy.

No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients

P. Viciana, L. López-Cortés, J. Pasquau, 2018, PloS one.

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2015, Medicine.

Darunavir Minimum Plasma Concentration and Ritonavir-Boosted Darunavir Monotherapy Outcome in HIV-Infected Patients

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2014, Antiviral therapy.

Q fever: epidemiology, clinical features and prognosis. A study from 1983 to 1999 in the South of Spain.

E. Cordero, J. Pachón, J. L. Villanueva, 2003, The Journal of infection.

Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract.

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The relationship between antiretroviral prescription patterns and treatment guidelines in treatment‐naïve HIV‐1‐infected patients

E. Ribera, J. Cosín, P. Viciana, 2009, HIV medicine.

VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naïve HIV-Infected Patients

M. Muñoz-Fernández, S. Resino, J. Bellón, 2019, Journal of clinical medicine.

[Reasons for antiretroviral treatment change in HIV+ patients in Spain in 2010-2011. SWITCH AUDIT Study].

P. Viciana, E. Pedrol, J. Pasquau, 2014, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

HIV infection-related premature immunosenescence: high rates of immune exhaustion after short time of infection.

E. Ruiz-Mateos, M. Leal, M. Muñoz-Fernández, 2011, Current HIV research.

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Increased regulatory T cell counts in HIV-infected nonresponders to hepatitis B virus vaccine.

M. Leal, Y. Pacheco, P. Viciana, 2010, The Journal of infectious diseases.

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

S. Arias-Santiago, E. Ruiz-Mateos, P. Viciana, 2020, Stem cells translational medicine.

and Cytological Status in a Spanish Cohort Sex with Men by Geographical Origin, Age, Distribution in HIV-Infected Men Who Have Anal Human Papillomavirus Genotype

J. Blanco, C. Rodríguez, P. Viciana, 2014 .

Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple Therapy

P. Viciana, L. López-Cortés, N. Espinosa, 2015, Antimicrobial Agents and Chemotherapy.

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Hansjakob Furrer, Manuel Battegay, Pietro Vernazza, 2019, The Lancet.

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

M. Salavert, F. Vidal, P. Viciana, 2012, AIDS.

Visceral leishmaniasis in HIV‐1 -infected individuals: a common opportunistic infection in Spain?

M. Leal, I. Velez, J. Pineda, 1992, AIDS.

Pharmacokinetics of zidovudine in end‐stage renal disease: influence of haemodialysis

J. Pachón, J. Cisneros, P. Viciana, 1992, AIDS.

The changing etiology of fever of intermediate duration.

M. Bernabeu-Wittel, J. Pachón, P. Viciana, 2010, Enfermedades infecciosas y microbiologia clinica.

[Psittacosis of avian origin as etiology of community-acquired pneumonia with severe onset].

J. Pachón, V. Martín-Sanz, P. Viciana, 1993, Revista clínica española (Ed. impresa).

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.

Pietro Vernazza, Simon Collins, Gilles Wandeler, 2016, JAMA.

[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].

Santiago Pérez-Hoyos, Santiago Moreno, Félix Gutiérrez, 2007, Enfermedades infecciosas y microbiologia clinica.

Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.

P. Viciana, L. López-Cortés, N. Espinosa, 2019, Vaccine.

Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events

A. Rivero, P. Viciana, F. Lozano, 2009, Annals of Internal Medicine.

Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone.

C. Tural, V. Soriano, J. Macías, 2008, The Journal of antimicrobial chemotherapy.

Once-daily antiretroviral therapy: Spanish Consensus Statement.

D. Podzamczer, J. Mallolas, J. Ena, 2005, The Journal of antimicrobial chemotherapy.

Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients

P. Viciana, L. López-Cortés, A. Marín-Niebla, 2007, Antimicrobial Agents and Chemotherapy.

Safety and Efficacy of Once-Daily Didanosine, Tenofovir and Nevirapine as a Simplification Antiretroviral Approach

B. Clotet, L. Ruiz, E. Negredo, 2003, Antiviral therapy.

Pharmacokinetic Interactions Between Efavirenz and Rifampicin in HIV-Infected Patients with Tuberculosis

J. Pachón, P. Viciana, L. López-Cortés, 2002, Clinical pharmacokinetics.

Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy.

J. Pachón, P. Viciana, L. López-Cortés, 2003, Journal of acquired immune deficiency syndromes.

Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort Facing Hepatitis A Outbreaks in the Clinical Practice

P. Viciana, L. López-Cortés, N. Espinosa, 2019, Journal of acquired immune deficiency syndromes.

Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.

J. Castilla, F. Vidal, S. Moreno, 2006, AIDS research and human retroviruses.

Efavirenz plasma concentrations and efficiency.

A. de Alarcón, P. Viciana, L. López-Cortés, 2001, AIDS.

Rilpivirine: The Key for Long-term Success.

P. Viciana, 2017, AIDS reviews.

Murine typhus as a common cause of fever of intermediate duration: a 17-year study in the south of Spain.

M. Bernabeu-Wittel, J. Pachón, J. L. Villanueva, 1999, Archives of internal medicine.

Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study

A. Rivero, P. Viciana, L. López-Cortés, 2010, AIDS research and therapy.

[Paraproteinemias in patients infected with the human immunodeficiency virus].

J. Pachón, P. Viciana, J. Pérez-Hurtado, 1991, Medicina clinica.

Very low level viraemia and risk of virological failure in treated HIV‐1‐infected patients

E. Ribera, P. Viciana, P. Geijo, 2017, HIV medicine.

Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort

M. Leal, F. Vidal, J. Blanco, 2006, PloS one.

Discontinuation of antiretroviral therapy in patients with chronic HIV infection: clinical, virologic, and immunologic consequences.

J. Cisneros, A. de Alarcón, P. Viciana, 2005, AIDS patient care and STDs.

[Activity of adenosine deaminase in acute brucellosis and complicated brucellosis].

J. A. Cuello, J. Pachón, P. Viciana, 1991, Medicina clinica.

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations

P. Viciana, L. López-Cortés, N. Espinosa, 2018, Journal of the International AIDS Society.

HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.

B. Walker, C. Tural, M. Lichterfeld, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rate and predictors of progression in elite and viremic HIV-1 controllers

Felipe García, J. Gatell, J. Benito, 2016, AIDS.

Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort.

S. Pérez-Hoyos, S. Moreno, J. Oteo, 2007, Journal of women's health.

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

Lidia Ruiz, Bonaventura Clotet, B. Clotet, 2002, AIDS.

OriginalHIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patientsP24 y recuentos de CD4 durante el tratamiento con inhibidores de la proteasa potenciados en monoterapia

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2017 .

HIV-1 p24 and CD4+ T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients.

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2017, Enfermedades infecciosas y microbiologia clinica.

Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks

J. Pachón, J. Colmenero, P. Viciana, 1990, Antimicrobial Agents and Chemotherapy.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class.

F. García, P. Viciana, F. Gutiérrez, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis C virus replication in Caucasian HIV controllers

E. Ruiz-Mateos, M. Leal, M. Genebat, 2011, Journal of viral hepatitis.

Anal Human Papillomavirus Genotype Distribution in HIV-Infected Men Who Have Sex with Men by Geographical Origin, Age, and Cytological Status in a Spanish Cohort

J. del Romero, J. Blanco, B. Hernández-Novoa, 2013, Journal of Clinical Microbiology.

IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals.

M. R. Benhnia, E. Ruiz-Mateos, M. Leal, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Absolute CD4+ T cell count overstate immune recovery assessed by CD4+/CD8+ ratio in HIV-infected patients on treatment

P. Viciana, L. López-Cortés, N. Espinosa, 2018, PloS one.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2015, Medicine.

Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy

Reyes Martín-Peña, P. Viciana, L. López-Cortés, 2014, AIDS.

Immune activation throughout a boosted darunavir monotherapy simplification strategy.

P. Viciana, A. Torres-Cornejo, R. Ruiz-Valderas, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

P. Viciana, L. López-Cortés, Z. Palacios-Baena, 2016, PloS one.

Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection.

E. Cordero, J. Pachón, P. Viciana, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.

J. Blanco, S. Moreno, F. Pulido, 2016, The Journal of infection.

ACSM4 Polymorphisms Are Associated With Rapid AIDS Progression in HIV-Infected Patients

M. Muñoz-Fernández, V. Soriano, S. Resino, 2014, Journal of acquired immune deficiency syndromes.

Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia

M. McConnell, F. Fernández-Cuenca, P. Viciana, 2011, Journal of acquired immune deficiency syndromes.

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.

J. Macías, J. Pineda, A. Rivero, 2008, The Journal of antimicrobial chemotherapy.

Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections.

P. Garcia-Lorda, J. Salas-Salvadó, M. Bulló, 2000, JPEN. Journal of parenteral and enteral nutrition.

[Thrombotic thrombocytopenic purpura in a patient with the acquired immunodeficiency syndrome].

J. Pachón, P. Viciana, I. Espigado, 1990, Revista clínica española (Ed. impresa).

[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].

B. Clotet, J. Miro, J. Gatell, 2004, Enfermedades infecciosas y microbiologia clinica.

Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort

S. Moreno, P. Arazo, P. Viciana, 2014, HIV Medicine.

Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

E. Ruiz-Mateos, J. Muñoz-Pichardo, A. Rivero, 2019, The Journal of antimicrobial chemotherapy.

What drives the number of high-risk human papillomavirus types in the anal canal in HIV-positive men who have sex with men?

R. Geskus, J. del Romero, J. Blanco, 2013, The Journal of infectious diseases.

High-risk human papilloma virus testing improves diagnostic performance to predict moderate-to-high grade anal intraepithelial neoplasia in HIV-infected men who have sex with men in low-to-absent cytological abnormalities.

P. Viciana, L. López-Cortés, N. Espinosa, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients

P. Viciana, L. López-Cortés, N. Espinosa, 2016, The Journal of antimicrobial chemotherapy.

Risk factors, CD4 long-term evolution and mortality of HIV-infected patients who persistently maintain low CD4 counts, despite virological response to HAART.

M. Leal, Y. Pacheco, F. Vidal, 2009, Current HIV research.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

Etiology of solitary pulmonary nodules in patients with human immunodeficiency virus infection.

J. Pachón, P. Viciana, J. Martín-Juan, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Analysis of Non-AIDS-Defining Events in HIV Controllers.

Felipe García, J. Benito, A. León, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Retroperitoneal fibrosis in a patient with human immunodeficiency virus infection.

E. Cordero, J. Pachón, P. Viciana, 1998, Archives of internal medicine.

Mitochondrial Haplogroups Are Associated With Clinical Pattern of AIDS Progression in HIV-Infected Patients

M. Muñoz-Fernandez, M. Riera, C. Rodríguez, 2013, Journal of acquired immune deficiency syndromes.

Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults.

F. García, S. Moreno, C. Rodríguez, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.

P. Viciana, L. López-Cortés, A. Torres-Cornejo, 2016, AIDS research and human retroviruses.

High levels of CD57+CD28- T-cells, low T-cell proliferation and preferential expansion of terminally differentiated CD4+ T-cells in HIV-elite controllers.

E. Ruiz-Mateos, M. Leal, M. Genebat, 2010, Current HIV research.

Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected Patients

P. Viciana, L. López-Cortés, E. Sánchez-Rivas, 2013, Antimicrobial Agents and Chemotherapy.

Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count.

M. Plana, M. Arnedo, J. Benito, 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy.

M. Leal, M. Salavert, F. Vidal, 2008, Current HIV research.

[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].

J. Miro, A. Antela, P. Viciana, 2000, Enfermedades infecciosas y microbiologia clinica.

Alternation of Antiretroviral Drug Regimens for HIV Infection

Lidia Ruiz, Kurt Hertogs, Ayumi Shintani, 2003, Annals of Internal Medicine.

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status.

M. Leal, M. Leal, F. Vidal, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010

M. Leal, F. Fernández-Cuenca, P. Viciana, 2011, Virology Journal.

Impact of the peginterferon‐α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV‐co‐infected patients with the unfavourable non‐CC IL28B genotypes

P. Viciana, L. Jiménez-Jiménez, A. Torres-Cornejo, 2014, Journal of viral hepatitis.

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

E. Ribera, J. Arribas, J. Cosín, 2002, AIDS.

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014

J. Macías, J. Pineda, P. Viciana, 2016, BMC Infectious Diseases.

Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients

B. Domínguez-Molina, P. Viciana, L. López-Cortés, 2018, The Journal of infectious diseases.

Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study

P. Viciana, A. Ocampo, H. Hevia, 2016, AIDS care.

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients

J. Torre-Cisneros, A. Gordon, J. Pineda, 2014, PloS one.

[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].

J. Miro, J. Gatell, E. Martinez, 2002, Enfermedades infecciosas y microbiologia clinica.

Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell‐associated viruses at viral replication episodes during darunavir/ritonavir monotherapy

P. Viciana, A. Torres-Cornejo, R. Ruiz-Valderas, 2015, HIV medicine.

Differential Gag-Specific Polyfunctional T Cell Maturation Patterns in HIV-1 Elite Controllers

R. Koup, J. Casazza, E. Ruiz-Mateos, 2012, Journal of Virology.

Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain

M. Bleda, S. Moreno, F. Pulido, 2010, BMC infectious diseases.

[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].

B. Clotet, J. Miro, J. Gatell, 2004 .

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

Analysis of Non-AIDS-Defining Events in HIV Controllers.

Felipe García, J. Benito, A. León, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dyslipidemia and Cardiovascular Disease Risk Factor Management in HIV-1-Infected Subjects Treated with HAART in the Spanish VACH Cohort

E. Ribera, J. Cosín, P. Viciana, 2008, The open AIDS journal.

Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects.

D. Podzamczer, B. Clotet, G. Sirera, 2004, Vaccine.